RBC Europe’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-112
| Closed | -$11K | – | 649 |
|
|
2021
Q4 | $11K | Hold |
112
| – | – | ﹤0.01% | 519 |
|
|
2021
Q3 | $9.75K | Hold |
112
| – | – | ﹤0.01% | 940 |
|
|
2021
Q2 | $9.18K | Hold |
112
| – | – | ﹤0.01% | 973 |
|
|
2021
Q1 | $10.7K | Sell |
112
-181
| -62% | -$17.2K | ﹤0.01% | 899 |
|
|
2020
Q4 | $18.2K | Hold |
293
| – | – | ﹤0.01% | 744 |
|
|
2020
Q3 | $17.4K | Hold |
293
| – | – | ﹤0.01% | 671 |
|
|
2020
Q2 | $20.5K | Sell |
293
-281
| -49% | -$19.6K | ﹤0.01% | 625 |
|
|
2020
Q1 | $26K | Hold |
574
| – | – | ﹤0.01% | 508 |
|
|
2019
Q4 | $37.3K | Hold |
574
| – | – | ﹤0.01% | 520 |
|
|
2019
Q3 | $35.6K | Buy |
574
+281
| +96% | +$17.4K | ﹤0.01% | 510 |
|
|
2019
Q2 | $20.9K | Hold |
293
| – | – | ﹤0.01% | 645 |
|
|
2019
Q1 | $23K | Hold |
293
| – | – | ﹤0.01% | 623 |
|
|
2018
Q4 | $24.8K | Hold |
293
| – | – | ﹤0.01% | 591 |
|
|
2018
Q3 | $50.2K | Hold |
293
| – | – | 0.01% | 476 |
|
|
2018
Q2 | $37.9K | Sell |
293
-2
| -0.7% | -$259 | ﹤0.01% | 529 |
|
|
2018
Q1 | $30.4K | Hold |
295
| – | – | ﹤0.01% | 582 |
|
|
2017
Q4 | $25.2K | Hold |
295
| – | – | ﹤0.01% | 626 |
|
|
2017
Q3 | $25.1K | Buy |
+295
| New | +$25.1K | ﹤0.01% | 635 |
|